Results 111 to 120 of about 313,523 (292)

Coherent Forecasting of Realized Volatility

Journal of Forecasting, EarlyView.
ABSTRACT The QLIKE loss function is the stylized favorite of the literature on volatility forecasting when it comes to out‐of‐sample evaluation and the state of the art model for realized volatility (RV) forecasting is the HAR model, which minimizes the squared error loss for in‐sample estimation of the parameters.
Marius Puke, Karsten Schweikert
wiley   +1 more source

Christian milestones in global health: The Declarations of Tübingen

, 2016
The conferences on Christian Health Care which were hold in Tuebingen (Germany) in 1964 and 1967 are a foundation for understanding the role of Christian health care services in the healing ministry of the church.
S. Flessa
semanticscholar   +1 more source

Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Journal of Inflammation Research
Tobias Harm,1 Anne-Katrin Rohlfing,1 Jessica Kristin Henes,1 Nicole Manzat,1 Michal Droppa,1 Malte N Bongers,2 Mathias Heikenwaelder,3,4 Karin Anne Lydia Müller,1 Meinrad Paul Gawaz,1 Dominik Rath1 1Department of Cardiology and Angiology, University ...
Harm T, Rohlfing AK, Henes JK, Manzat N, Droppa M, Bongers MN, Heikenwaelder M, Müller KAL, Gawaz MP, Rath D   +9 more
doaj  

Über Regie im Figurentheater – eine Utopie

Móin-Móin, 2018
O estudo analisa o percurso do Figuren Theater Tübingen e alguns procedimentos criativos utilizados pelo seu diretor, Frank Soehnle, em suas recentes encenações.
Frank Soehnle
doaj  

Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life

International Journal of Cancer, EarlyView.
What's New? Oxaliplatin serves a key role in the treatment of rectal cancer, though it is a significant cause of chemotherapy‐induced peripheral neuropathy. As total neoadjuvant therapy, in which all therapy is given before surgery, has become more common, understanding neuropathy has grown increasingly important. This study examined neuropathy and its
Georg W. Wurschi, Andreas Hinz, Melanie Schneider, Jan‐Niklas Becker, Bernd Frerker, Samuel M. Vorbach, Felix Ehret, Markus Diefenhardt, Fabian Schunn, Maria‐Elena von Gruben, Marcel Büttner, Elgin Hoffmann, Alexander Rühle, Josephine Beier, Simone Ferdinandus, Maike Trommer, Ezgi Ceren Sahin, Julian Hlouschek, Kynann Aninditha, Daphne Schepers von Ohlen, Justus Kaufmann, Alina Depardon, Hai Minh Ha, Christopher Kessler, Adrianna Cieslak, Simon Trommer, Alexander Fabian, Florian Rißner, Maximilian Römer, Klaus Pietschmann   +29 more
wiley   +1 more source

[Rezension zu:] Mary Snell-Hornby, Hans G. Hönig, Paul Kussmaul, Peter A. Schmitt (Hg.): Handbuch Translation. Tübingen: Stauffenburg Verlag 1998. (434 Seiten; ISBN: 3-86057-991-6) [PDF]

, 2012
Rezension zu Mary Snell-Hornby, Hans G. Hönig, Paul Kussmaul, Peter A. Schmitt (Hg,): Handbuch Translation. Tübingen: Stauffenburg Verlag 1998.
Harslem, Frank J.
core  

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

International Journal of Cancer, EarlyView.
What's New? Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor to multiple myeloma, sharing substantial genetic features with overt malignancy. Given evidence implicating autophagy in myeloma risk, this study examined whether genetic variations in autophagy‐related genes influence MGUS susceptibility.
José Manuel Sánchez‐Maldonado, Angelica Macauda, Antonio José Cabrera‐Serrano, Hauke Thomsen, Murat Güler, Rob Ter Horst, Bethany van Guelpen, Pavel Vodicka, Stefano Landi, Subhayan Chattopadhyay, Pelin Ünal, Lucía Ruiz‐Durán, Delphine Casabonne, Hartmut Goldschmidt, Istemi Serin, María Carretero‐Fernández, Elena Cabezudo, Fernando Reyes‐Zurita, Aaron D. Norman, Ramón García‐Sanz, Gabriele Capurso, Per Hoffmann, Ulrika Pettersson‐Kymmer, Francisco Jiménez‐Romera, S. Vincent Rajkumar, Niels Weinhold, Ludmila Vodickova, Christian Langer, Angelika Stein, Abdulkadir Karismaz, Victor Moreno, Markus M. Nöthen, Karl‐Heinz Jöckel, Francesca Tavano, Joaquín Martínez‐López, Shaji K. Kumar, Juan Francisco Gutiérrez‐Bautista, Daniela Basso, Florentin Späth, Yolanda Benavente, Michelle A. T. Hildebrandt, Börge Schmidt, Tereza Sevcikova, Rui Manuel Vieira Reis, Yang Li, Miguel Ángel López‐Nevot, Mihai G. Netea, Daniele Campa, Alyssa Clay‐Gilmour, Susan L Slager, Kari Hemminki, Celine M Vachon, Asta Försti, Federico Canzian, Juan Sainz   +54 more
wiley   +1 more source

Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP

Drug Design, Development and Therapy
Larissa N Ernst,1 Simon J Jaag,2 Valentin R Wydra,3 Benedikt Masberg,2 Cornelius Knappe,2 Stefan Gerstenecker,3 Ricardo AM Serafim,3 Xiaojun Julia Liang,4,5 Nico J Seidler,3,5 Michael Lämmerhofer,2 Matthias Gehringer,3– 5 Frank M Boeckler1,6 1Department ...
Ernst LN, Jaag SJ, Wydra VR, Masberg B, Knappe C, Gerstenecker S, Serafim RAM, Liang XJ, Seidler NJ, Lämmerhofer M, Gehringer M, Boeckler FM   +11 more
doaj  

PelviSound L—Real‐time intraoperative sonographic assessment of pelvic sentinel lymph nodes using a drop‐in probe in endometrial and cervical cancer during minimally invasive surgery: A single‐center pilot feasibility study in 20 patients

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Sentinel lymph node biopsy (SLNB) is considered an essential step in the surgical management of endometrial and cervical cancers as it has led to a reduction in the need for full pelvic lymphadenectomy. This proof‐of‐concept study aimed to evaluate the feasibility and diagnostic performance of intraoperative sonographic assessment of
Sascha Hoffmann, Laura Trif, Bernhard Krämer, Felix Neis, Diethelm Wallwiener, Sara Y. Brucker, Markus Hoopmann, Markus Hahn   +7 more
wiley   +1 more source

SNAr Reactive Pyrazine Derivatives as p53-Y220C Cleft Binders with Diverse Binding Modes

Drug Design, Development and Therapy
Theresa Klett,1 Jason Stahlecker,1 Martin Schwer,1 Simon J Jaag,2 Benedikt Masberg,2 Cornelius Knappe,2 Michael Lämmerhofer,2 Thilo Stehle,3 Frank M Boeckler1,4 1Laboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical
Klett T, Stahlecker J, Schwer M, Jaag SJ, Masberg B, Knappe C, Lämmerhofer M, Stehle T, Boeckler FM   +8 more
doaj